Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and …

MU Rehman, N Sehar, NJ Dar, A Khan, A Arafah… - Neuroscience & …, 2023 - Elsevier
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …

Mitochondria and antibiotics: for good or for evil?

JM Suárez-Rivero, CJ Pastor-Maldonado… - Biomolecules, 2021 - mdpi.com
The discovery and application of antibiotics in the common clinical practice has undeniably
been one of the major medical advances in our times. Their use meant a drastic drop in …

[HTML][HTML] Boosting mitochondrial health to counteract neurodegeneration

J Burtscher, M Romani, G Bernardo, T Popa… - Progress in …, 2022 - Elsevier
Mitochondrial health is based on a delicate balance of specific mitochondrial functions (eg
metabolism, signaling, dynamics) that are impaired in neurodegenerative diseases …

[HTML][HTML] Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

A Dominguez-Meijide, V Parrales, E Vasili… - Neurobiology of …, 2021 - Elsevier
Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are neurodegenerative
disorders characterized by the misfolding and aggregation of alpha-synuclein (aSyn) …

Therapeutic implications of phosphorylation-and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

N Khakha, H Khan, A Kaur, TG Singh - Pharmacological Reports, 2023 - Springer
Neurodegeneration is a condition of the central nervous system (CNS) characterized by loss
of neural structures and function. The most common neurodegenerative disorders (NDDs) …

Beyond animal models: Revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting

P Teli, V Kale, A Vaidya - Cell and tissue research, 2023 - Springer
Neurodegenerative diseases (NDs) are characterized by uncontrolled loss of neuronal cells
leading to a progressive deterioration of brain functions. The transition rate of numerous …

Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways …

X Yang, S Chu, Z Wang, F Li, Y Yuan… - Acta Pharmacologica …, 2021 - nature.com
Huntington's disease (HD) is one of main neurodegenerative diseases, characterized by
striatal atrophy, involuntary movements, and motor incoordination. Ginsenoside Rg1 (Rg1) …

Pyroptotic cell death in the R6/2 mouse model of Huntington's disease: new insight on the inflammasome

E Paldino, V D'Angelo, G Sancesario, FR Fusco - Cell death discovery, 2020 - nature.com
Mechanisms of tissue damage in Huntington's disease involve excitotoxicity, mitochondrial
damage, and neuroinflammation, including microglia activation. In the present study, we …

Oxidative stress and neurodegeneration: Interconnected processes in polyq diseases

I Gkekas, A Gioran, MK Boziki, N Grigoriadis… - Antioxidants, 2021 - mdpi.com
Neurodegenerative polyglutamine (polyQ) disorders are caused by trinucleotide repeat
expansions within the coding region of disease-causing genes. PolyQ-expanded proteins …

Inflammation and Parkinson's disease pathogenesis: mechanisms and therapeutic insight

G Forloni, P La Vitola, M Cerovic, C Balducci - Progress in Molecular …, 2021 - Elsevier
Abstract After Alzheimer's disease, Parkinson's disease is the most frequent
neurodegenerative disorder. Although numerous treatments have been developed to control …